Showing results (1871-1880 of 2,113) with videos related to

Sort By:
Pageof 212
Journal of the International Neuropsychological Society : JINS|October 31, 2002
Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinationsTanis J Ferman, Bradley F Boeve, Glenn E Smith, et al.
Neoplasia (New York, N.Y.)|October 19, 2005
TWIST is expressed in human gliomas and promotes invasionMaria C Elias, Kathleen R Tozer, John R Silber, et al.
JMIR Mhealth and Uhealth|May 16, 2022
Early Detection of Neurodevelopmental Disorders of Toddlers and Postnatal Depression by Mobile Health App: Observational Cross-sectional StudyFabrice Denis, Laura Maurier, Kevin Carillo, et al.
North American Spine Society Journal|December 19, 2024
Association between modifiable and nonmodifiable risk factors with paralumbar muscle health in patients with lower back painJohn Fallon, Jonathan Sgaglione, Matthew Rohde, et al.
Journal of Virological Methods|March 5, 2011
Monkey CV1 cell line expressing the sheep-goat SLAM protein: a highly sensitive cell line for the isolation of peste des petits ruminants virus from pathological specimensCaroline Mélanie Adombi, Mamadou Lelenta, Charles Euloge Lamien, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 casesT J Walsh, J W Hiemenz, N L Seibel, et al.
Health Services Research|March 5, 2014
Template matching for auditing hospital cost and qualityJeffrey H Silber, Paul R Rosenbaum, Richard N Ross, et al.
Antimicrobial Resistance and Infection Control|January 26, 2021
Enhancing engagement beyond the conference walls: analysis of Twitter use at #ICPIC2019 infection prevention and control conferenceRomain Martischang, Ermira Tartari, Claire Kilpatrick, et al.
Biophysical Journal|May 28, 2019
Modulating Hinge Flexibility in the APP Transmembrane Domain Alters γ-Secretase CleavageAlexander Götz, Nadine Mylonas, Philipp Högel, et al.
European Journal of Gastroenterology & Hepatology|December 4, 2025
A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adultsJeffrey L Silber, Jason M Norman, Tokuwa Kanno, et al.
Pageof 212